Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.
about
Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer.Osteopontin Peptide Icosamer Containing RGD and SLAYGLR Motifs Enhances the Motility and Phagocytic Activity of Microglia.Proangiogenic functions of an RGD-SLAY-containing osteopontin icosamer peptide in HUVECs and in the postischemic brain.PCL films of varying porosity influence ICAM-1 expression of HUVECs.
P2860
Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.
@en
type
label
Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.
@en
prefLabel
Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.
@en
P2093
P356
P1476
Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma
@en
P2093
Ariadna Pérez-Balaguer
Eloy Pomares-Navarro
Enrique Lerma
Fernando Ortiz-Martínez
Gloria Peiró
José Sánchez-Payá
Leire Andrés
P304
P356
10.1309/AJCP6F2VNDAMSULA
P407
P577
2015-06-01T00:00:00Z